Literature DB >> 15786465

Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia.

Hahn Young Kim1, Aneesh B Singhal, Eng H Lo.   

Abstract

A major limitation in thrombolysis for acute ischemic stroke is the restricted time window for safe and effective therapy. Any method that can extend the reperfusion time window would be important. In this study, we show that normobaric hyperoxia extends the time window for effective reperfusion from 1 to 3 hours in rats subjected to focal cerebral ischemia. Normobaric hyperoxia did not increase cellular markers of superoxide generation or brain levels of matrix metalloproteinase-9. Normobaric hyperoxia may be a clinically feasible adjunct method for significantly increasing the time window for effective thrombolytic therapy in acute ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786465     DOI: 10.1002/ana.20430

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  46 in total

1.  Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke.

Authors:  Hwa Kyoung Shin; Fumiaki Oka; Ji Hyun Kim; Dmitriy Atochin; Paul L Huang; Cenk Ayata
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 2.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

Review 3.  Advances in emerging nondrug therapies for acute stroke 2007.

Authors:  Aneesh B Singhal; Eng H Lo
Journal:  Stroke       Date:  2008-01-10       Impact factor: 7.914

Review 4.  Experimental models, neurovascular mechanisms and translational issues in stroke research.

Authors:  E H Lo
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

Review 5.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

Review 6.  Hyperbaric oxygen therapy in acute stroke: is it time for Justitia to open her eyes?

Authors:  Milija D Mijajlovic; Vuk Aleksic; Nenad Milosevic; Natan M Bornstein
Journal:  Neurol Sci       Date:  2020-01-11       Impact factor: 3.307

7.  Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.

Authors:  Hiroaki Manabe; David O Okonkwo; John L Gainer; Ryon H Clarke; Kevin S Lee
Journal:  J Neurosurg       Date:  2010-10       Impact factor: 5.115

8.  Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia.

Authors:  Wenlan Liu; Jill Hendren; Xu-Jun Qin; Jiangang Shen; Ke Jian Liu
Journal:  J Neurochem       Date:  2009-02       Impact factor: 5.372

9.  Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.

Authors:  Wenlan Liu; Rohit Sood; Qingchuan Chen; Unal Sakoglu; Jill Hendren; Ozdemir Cetin; Minoru Miyake; Ke Jian Liu
Journal:  J Neurochem       Date:  2008-09-11       Impact factor: 5.372

10.  Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.

Authors:  Norio Fujiwara; Yoshihiro Murata; Ken Arai; Yasuhiro Egi; Jie Lu; Ona Wu; Aneesh B Singhal; Eng H Lo
Journal:  BMC Neurosci       Date:  2009-07-15       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.